593 related articles for article (PubMed ID: 24095746)
41. Synthesis and cytotoxicity of 3-aryl acrylic amide derivatives of the simplified saframycin-ecteinascidin skeleton prepared from L-dopa.
Guo J; Dong W; Liu W; Yan Z; Wang N; Liu Z
Eur J Med Chem; 2013 Apr; 62():670-6. PubMed ID: 23434640
[TBL] [Abstract][Full Text] [Related]
42. One-pot synthesis and antiproliferative activity of novel 2,4-diaminopyrimidine derivatives bearing piperidine and piperazine moieties.
Ma WF; Yang HK; Hu MJ; Li Q; Ma TZ; Zhou ZZ; Liu RY; You WW; Zhao PL
Eur J Med Chem; 2014 Sep; 84():127-34. PubMed ID: 25016234
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents.
Altıntop MD; Özdemir A; Turan-Zitouni G; Ilgın S; Atlı Ö; İşcan G; Kaplancıklı ZA
Eur J Med Chem; 2012 Dec; 58():299-307. PubMed ID: 23142671
[TBL] [Abstract][Full Text] [Related]
44. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties.
Shareef MA; Duscharla D; Ramasatyaveni G; Dhoke NR; Das A; Ummanni R; Srivastava AK
Eur J Med Chem; 2015 Jan; 89():128-37. PubMed ID: 25462233
[TBL] [Abstract][Full Text] [Related]
45. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
[TBL] [Abstract][Full Text] [Related]
46. The synthesis of 4,6-diaryl-2-pyridones and their bioactivation in CYP1 expressing breast cancer cells.
Ruparelia KC; Lodhi S; Ankrett DN; Wilsher NE; Arroo RRJ; Potter GA; Beresford KJM
Bioorg Med Chem Lett; 2019 Jun; 29(11):1403-1406. PubMed ID: 30935796
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and antiproliferative activity of some new thieno[2,3-d]pyrimidin-4(3H)-ones containing 1,2,4-triazole and 1,3,4-thiadiazole moiety.
Mavrova ATs; Wesselinova D; Tsenov JA; Lubenov LA
Eur J Med Chem; 2014 Oct; 86():676-83. PubMed ID: 25222878
[TBL] [Abstract][Full Text] [Related]
48. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
49. A novel methodology for synthesis of dihydropyrazole derivatives as potential anticancer agents.
Wang X; Pan YM; Huang XC; Mao ZY; Wang HS
Org Biomol Chem; 2014 Apr; 12(13):2028-32. PubMed ID: 24519368
[TBL] [Abstract][Full Text] [Related]
50. Microwave-assisted synthesis of 2(1H)-pyridones and their glucosides as cell proliferation inhibitors.
Al-Neyadi SS; Hassan AH; Abdou IM
Nucleosides Nucleotides Nucleic Acids; 2011 Feb; 30(2):120-34. PubMed ID: 21360410
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and cytotoxic activity of some novel steroidal C-17 pyrazolinyl derivatives.
Fan NJ; Tang JJ; Li H; Li XJ; Luo B; Gao JM
Eur J Med Chem; 2013 Nov; 69():182-90. PubMed ID: 24021891
[TBL] [Abstract][Full Text] [Related]
52. Design, synthesis and anticancer activity evaluation of some novel pyrrolo[1,2-a]azepine derivatives.
Belal A
Arch Pharm (Weinheim); 2014 Jul; 347(7):515-22. PubMed ID: 24729464
[TBL] [Abstract][Full Text] [Related]
53. New titanocene derivatives with high antiproliferative activity against breast cancer cells.
Saturnino C; Sirignano E; Botta A; Sinicropi MS; Caruso A; Pisano A; Lappano R; Maggiolini M; Longo P
Bioorg Med Chem Lett; 2014 Jan; 24(1):136-40. PubMed ID: 24332626
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and anticancer activity of acyl thioureas bearing pyrazole moiety.
Koca İ; Özgür A; Coşkun KA; Tutar Y
Bioorg Med Chem; 2013 Jul; 21(13):3859-65. PubMed ID: 23664495
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents.
Ma LY; Zheng YC; Wang SQ; Wang B; Wang ZR; Pang LP; Zhang M; Wang JW; Ding L; Li J; Wang C; Hu B; Liu Y; Zhang XD; Wang JJ; Wang ZJ; Zhao W; Liu HM
J Med Chem; 2015 Feb; 58(4):1705-16. PubMed ID: 25610955
[TBL] [Abstract][Full Text] [Related]
56. Synthesis, structure-activity relationship and biological evaluation of novel nitrogen mustard sophoridinic acid derivatives as potential anticancer agents.
Li DD; Dai LL; Zhang N; Tao ZW
Bioorg Med Chem Lett; 2015 Oct; 25(19):4092-6. PubMed ID: 26299348
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
[TBL] [Abstract][Full Text] [Related]
58. Synthesis of 1-acetyl-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and evaluation of their anticancer activity.
Özdemir A; Altıntop MD; Kaplancıklı ZA; Turan-Zitouni G; Ciftçi GA; Yıldırım SU
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1221-7. PubMed ID: 23020635
[TBL] [Abstract][Full Text] [Related]
59. Synthesis of novel thiazolyl-pyrimidines and their anticancer activity in vitro.
Shi HB; Li HB; Lu KQ; Zhu XR; Hu WX; Pei W
Arch Pharm (Weinheim); 2011 Oct; 344(10):675-83. PubMed ID: 21984017
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
